Edwards Lifesciences Corp
EW
49 insider filings · Latest: Jul 11, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Jul 10 9:04 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $91.70 | $56.8K | 40,033.91(D) | View → |
| Jun 30, 2026 | Jul 1 12:01 AM | Daniel J. LippisCVP, TAVR | Sale | 619 | $91.40 | $56.6K | 40,410.91(D) | View → |
| Jun 17, 2026 | Jun 18 12:19 AM | Bernard J ZovighianDirector, CEO | Sale | 523 | $87.92 | $46.0K | 11,516.551(I) | View → |
| May 29, 2026 | May 29 8:44 PM | Andrew M. DahlSVP, Corporate Controller | Sale | 567.527 | $86.08 | $48.9K | 15,334.095(D) | View → |
| May 29, 2026 | May 29 8:23 PM | Ullem Scott B. | Proposed Sale | 64,152 | $86.59 | $5.6M | — | View → |
| May 29, 2026 | May 29 8:12 PM | Dahl Andrew M. | Proposed Sale | 568 | $86.01 | $48.9K | — | View → |
| May 27, 2026 | May 27 11:28 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 23,145 | $86.42 | $2.0M | 98,611(I) | View → |
| May 27, 2026 | May 27 8:19 PM | BOBO JR FAMILY TRUST | Proposed Sale | 23,145 | $86.42 | $2.0M | — | View → |
| May 22, 2026 | May 22 8:35 PM | Daveen ChopraCVP, TMTT & Surgical | Sale | 1,500 | $84.60 | $126.9K | 44,324(D) | View → |
| May 22, 2026 | May 22 8:01 PM | Chopra Daveen | Proposed Sale | 1,500 | $84.60 | $126.9K | — | View → |
| May 18, 2026 | May 18 9:29 PM | Daniel J. LippisCVP, TAVR | Sale | 620 | $81.14 | $50.3K | 40,410.91(D) | View → |
| May 15, 2026 | May 18 9:28 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Sale | 17,968 | $81.96 | $1.5M | 30,969.576(I) | View → |
| May 18, 2026 | May 18 8:10 PM | Lippis Daniel J. | Proposed Sale | 1,858 | $81.14 | $150.8K | — | View → |
| May 15, 2026 | May 15 8:04 PM | BOBO DONALD E JR | Proposed Sale | 9,968 | $82.07 | $818.1K | — | View → |
| May 12, 2026 | May 12 8:55 PM | Bernard J ZovighianDirector, CEO | Sale | 36,351 | $77.93 | $2.8M | 12,039.551(I) | View → |
| May 12, 2026 | May 12 8:02 PM | Zovighian Bernard J | Proposed Sale | 36,874 | $77.93 | $2.9M | — | View → |
| May 11, 2026 | May 12 1:33 AM | Wayne MarkowitzCVP, JAPAC | Sale | 593 | $79.73 | $47.3K | 21,679.871(D) | View → |
| May 11, 2026 | May 11 8:10 PM | Markowitz Wayne | Proposed Sale | 593 | $79.73 | $47.3K | — | View → |
| May 4, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $83.98 | $85.6K | 33,681.91(D) | View → |
| May 1, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Sale | 1,019 | $83.01 | $84.6K | 33,933.91(D) | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Jul 10 9:11 PM | Theodora MistrasCVP, Chief Financial Officer | Grant/Award | 74,125 | $91.33 | 12,325(D) | View → |
| Jul 10, 2026 | Jul 10 9:04 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 4,952(D) | View → |
| Jun 30, 2026 | Jul 1 12:01 AM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 5,571(D) | View → |
| May 18, 2026 | May 18 9:29 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 620 | $72.68 | 6,190(D) | View → |
| May 11, 2026 | May 12 8:55 PM | Bernard J ZovighianDirector, CEO | Option Exercise | 47,207 | — | 0(D) | View → |
| May 11, 2026 | May 12 8:52 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 13,457 | — | 0(D) | View → |
| May 11, 2026 | May 12 8:50 PM | Daveen ChopraCVP, TMTT & Surgical | Option Exercise | 13,583 | — | 0(D) | View → |
| May 11, 2026 | May 12 1:59 AM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 19,830 | — | 0(D) | View → |
| May 7, 2026 | May 12 1:33 AM | Wayne MarkowitzCVP, JAPAC | Grant/Award | 31,600 | $82.76 | 5,200(D) | View → |
| May 7, 2026 | May 12 1:32 AM | Bernard J ZovighianDirector, CEO | Grant/Award | 289,100 | $82.76 | 43,800(D) | View → |
| May 7, 2026 | May 9 1:17 AM | Donald E Bobo JRCVP,Strategy/Corp Development | Grant/Award | 51,850 | $82.76 | 7,850(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Daniel J. LippisCVP, TAVR | Grant/Award | 47,750 | $82.76 | 7,850(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Andrew M. DahlSVP, Corporate Controller | Grant/Award | 6,745 | $82.76 | 6,745(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Daveen ChopraCVP, TMTT & Surgical | Grant/Award | 58,775 | $82.76 | 9,675(D) | View → |
| May 7, 2026 | May 9 1:15 AM | Annette BrulsCVP, EMEACLA | Grant/Award | 40,350 | $82.76 | 6,650(D) | View → |
| May 5, 2026 | May 5 11:08 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 0(D) | View → |
| May 4, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 0(D) | View → |
| May 1, 2026 | May 4 11:30 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 1,019(D) | View → |
| Apr 9, 2026 | Apr 9 11:34 PM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 13,000 | $59.26 | 13,000(D) | View → |
| Apr 6, 2026 | Apr 7 12:42 AM | Daniel J. LippisCVP, TAVR | Option Exercise | 1,019 | $59.26 | 2,038(D) | View → |
Page 1 of 2
Next →